Only 1% of Serious Adverse Drug Events Reported To FDA: Report

While federal health regulators and safety officials use adverse event data to identify potential risks associated with drugs or devices that are already on the market, a new report suggests that only a tiny fraction of issues are ever submitted, which may allow serious side effects to go unnoticed.

Researchers with the Institute for Safe Medication Practices (ISMP) indicate that only about 1% of all serious adverse drug reports are submitted to the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS), according to findings published this month in the group’s QuarterWatch Report.

The ISMP is an independent organization, which evaluates adverse event data submitted to the FDA, and issues a quarterly report that highlights potential trends or emerging risks based on reports submitted by consumers, physicians and manufacturers.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

In this latest report, researchers looked at five case studies from 2017, which included the best-documented adverse drug events. These included severe gastrointestinal problems linked to Mobic and Celebrex, movement disorders linked to Risperdal, bleeding events linked to Eliquis, and tuberculosis reports associated with Humira.

“Based on this sample of the best-documented adverse drug events, we estimate that approximately 1% of the serious injuries occurring are reported to FAERS,” the report states. “But the variability was large, ranging from fewer than 1 per thousand for some serious but frequent adverse events to a reporting rate of 7.6% for a rare but serious adverse effect of a newer drug receiving more post-market surveillance from the drug manufacturer.”

FAERs is the primary system used to monitor adverse drug events, and receives more than 400,000 reports of serious injury and death linked to medications every year. Conventional wisdom has always suggested that only about 10% of events were being reported, which suggests that as many as 4 million people nationwide suffer a serious or fatal injury every year.

With the variation in ranges from one drug to another, and other factors, the ISMP researchers ultimately calculated that number was closer to 5.7 million.

“These results from five in-depth case studies describe a useful range of estimates of both the number of injuries and the fraction reported to FAERS. They further support a conclusion repeated frequently in QuarterWatch reports: because of variability in reporting rate, the number of adverse event reports in this system does not provide reliable information to estimate the incidence of adverse events––but it helps establish the strength of the association,” the researchers determined. “Even viewed as an order of magnitude estimate of serious injuries attributable to therapeutic drugs, these data emphasize the need for better surveillance of the risk of injury from the therapeutic use of drugs, and more aggressive interventions to reduce risk and assure safe use.”

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Change Healthcare Data Breach Lawyers Meeting Today With MDL Judge For Initial Status Conference
Change Healthcare Data Breach Lawyers Meeting Today With MDL Judge For Initial Status Conference (Posted yesterday)

The judge presiding over all Change Healthcare lawsuits filed in federal court is holding the first status conference of the litigation, which is expected to grow significantly as Change Healthcare data breach letters continue to be sent to impacted customers.

Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury
Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury (Posted 2 days ago)

Complaint comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits filed in U.S. District Courts nationwide should be centralized before one judge.